Introduction: DNA damage is a ubiquitous threat to genomic integrity, posing a constant challenge to cells’ survival and proliferation. In cancer, dysregulation of DNA damage response (DDR) pathways can lead to genomic instability, a hallmark of tumorigenesis. Moreover, The complex mechanisms of DNA damage, repair, and mutagenesis in cancer development are essential for identifying therapeutic targets and then devising effective treatment strategies. This blog explains the molecular intricacies of DNA damage and repair in cancer, highlighting vulnerabilities that can be exploited for therapeutic intervention. DNA Damage and Repair Mechanisms: DNA damage can arise from various sources, including endogenous metabolic…
-
-
Introduction: In the pursuit of innovative cancer therapies, the intersection of immunotherapy and metabolic pathways has emerged as a promising frontier in oncology. Metabolic reprogramming is a hallmark of cancer, enabling tumor cells to sustain rapid proliferation and evade immune surveillance. Harnessing this metabolic plasticity to enhance immune responses and selectively target tumor cells represents a novel approach to cancer treatment. This blog explores the burgeoning field of targeted immunometabolic therapy, highlighting the intricate crosstalk between immune cells and metabolic pathways and its implications for cancer treatment. Metabolic Reprogramming in Cancer: Cancer cells exhibit profound alterations in cellular metabolism…
-
Introduction: The quest for more precise diagnostics and effective treatments is unending. Cancer, with its multifaceted nature and ability to adapt, necessitates innovative approaches to diagnosis and treatment. One such innovation that holds immense promise is the utilization of circulating tumor cells (CTCs) as biomarkers. CTCs, shed from primary tumors or metastatic sites into the bloodstream, offer a window into the dynamic nature of cancer, providing insights into disease progression and treatment response. This blog discusses the burgeoning field of CTC research, exploring their utility as biomarkers for diagnosis, prognosis, and treatment monitoring, and their potential to drive advancements in…